The Drug Enforcement Administration published a year-long extension of telemedicine prescribing flexibilities for controlled ...

DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.

Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency.

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration system for the remote prescribing of controlled substances. An ...

EXTON, Pa., Sept. 24, 2025 /PRNewswire/ -- ProRx Pharma, the leading health and wellness 503B outsourcing facility, announced today it has been awarded a DEA Controlled Substances Registration ...

In an April 2 letter, a group of over 200 stakeholders urged the Drug Enforcement Administration (DEA) to release a revised proposed rule that would “permit and regulate the prescribing of controlled ...

The Drug Enforcement Agency has published a new final rule adjusting the fee schedule for its Diversion Control Program, which includes a more than 30 percent increase in the registration fee assessed ...

The U.S. Drug Enforcement Agency has released its notice of proposed rulemaking for a framework to permit medically necessary controlled substances without an in-person visit without violating the ...

Advocacy groups, providers and virtual care companies said clinicians and pharmacies need time to comment on the rule and prepare for implementation. During the COVID-19 public health emergency, ...